DK2726091T3 - Præparater med terapeutisk middel til fremføring i et lumen i tarmkanalen ved hjælp af en synkbar anordning til lægemiddelfremføring - Google Patents

Præparater med terapeutisk middel til fremføring i et lumen i tarmkanalen ved hjælp af en synkbar anordning til lægemiddelfremføring Download PDF

Info

Publication number
DK2726091T3
DK2726091T3 DK12803759.5T DK12803759T DK2726091T3 DK 2726091 T3 DK2726091 T3 DK 2726091T3 DK 12803759 T DK12803759 T DK 12803759T DK 2726091 T3 DK2726091 T3 DK 2726091T3
Authority
DK
Denmark
Prior art keywords
supply
syncable
lumen
preparations
gas channel
Prior art date
Application number
DK12803759.5T
Other languages
English (en)
Inventor
Mir Imran
Original Assignee
Rani Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rani Therapeutics Llc filed Critical Rani Therapeutics Llc
Application granted granted Critical
Publication of DK2726091T3 publication Critical patent/DK2726091T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • A61B1/041—Capsule endoscopes for imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/07—Endoradiosondes
    • A61B5/073—Intestinal transmitters
DK12803759.5T 2011-06-29 2012-06-29 Præparater med terapeutisk middel til fremføring i et lumen i tarmkanalen ved hjælp af en synkbar anordning til lægemiddelfremføring DK2726091T3 (da)

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
US201161571634P 2011-06-29 2011-06-29
US201161571679P 2011-06-29 2011-06-29
US201161571641P 2011-06-29 2011-06-29
US201161571632P 2011-06-29 2011-06-29
US201161571643P 2011-06-29 2011-06-29
US201161571633P 2011-06-29 2011-06-29
US201161571686P 2011-06-29 2011-06-29
US201161571687P 2011-06-29 2011-06-29
US201161571650P 2011-06-30 2011-06-30
US201161571619P 2011-06-30 2011-06-30
US201161571648P 2011-06-30 2011-06-30
US201161571642P 2011-06-30 2011-06-30
US201161571649P 2011-06-30 2011-06-30
US201161571631P 2011-06-30 2011-06-30
US201161571652P 2011-06-30 2011-06-30
PCT/US2012/045138 WO2013003824A1 (en) 2011-06-29 2012-06-29 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Publications (1)

Publication Number Publication Date
DK2726091T3 true DK2726091T3 (da) 2020-03-09

Family

ID=47424583

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12803759.5T DK2726091T3 (da) 2011-06-29 2012-06-29 Præparater med terapeutisk middel til fremføring i et lumen i tarmkanalen ved hjælp af en synkbar anordning til lægemiddelfremføring

Country Status (10)

Country Link
EP (2) EP2726091B1 (da)
JP (5) JP6029664B2 (da)
CN (2) CN109008910A (da)
AU (1) AU2012275112B2 (da)
CA (2) CA3070695C (da)
DK (1) DK2726091T3 (da)
ES (1) ES2773115T3 (da)
PL (1) PL2726091T3 (da)
PT (1) PT2726091T (da)
WO (1) WO2013003824A1 (da)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109157742B (zh) 2009-08-03 2022-04-05 因卡伯实验室有限责任公司 用于刺激肠道内肠促胰岛素产生的吞咽式囊和方法
US8759284B2 (en) 2009-12-24 2014-06-24 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
MX354016B (es) 2010-09-15 2018-02-07 J Mrsny Randall Sistemas y metodos de suministro de agentes bioactivos mediante el uso de secuencias transportadoras derivadas de toxinas.
US11246915B2 (en) 2010-09-15 2022-02-15 Applied Molecular Transport Inc. Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
US9259386B2 (en) 2010-12-23 2016-02-16 Rani Therapeutics, Llc Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402807B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402806B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8734429B2 (en) 2010-12-23 2014-05-27 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US9283179B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9629799B2 (en) 2010-12-23 2017-04-25 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US10639272B2 (en) 2010-12-23 2020-05-05 Rani Therapeutics, Llc Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
US8846040B2 (en) 2010-12-23 2014-09-30 Rani Therapeutics, Llc Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9861683B2 (en) 2010-12-23 2018-01-09 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809269B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9415004B2 (en) 2010-12-23 2016-08-16 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9149617B2 (en) 2010-12-23 2015-10-06 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US8809271B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8980822B2 (en) 2010-12-23 2015-03-17 Rani Therapeutics, Llc Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8969293B2 (en) 2010-12-23 2015-03-03 Rani Therapeutics, Llc Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8764733B2 (en) 2010-12-23 2014-07-01 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9284367B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
CN109008910A (zh) * 2011-06-29 2018-12-18 拉尼医疗有限公司 用于使用可吞服药物递送装置递送到肠道内腔中的治疗药剂制剂
CN105263461B (zh) * 2013-03-15 2019-09-10 拉尼医疗有限公司 用于治疗化合物的口服递送的装置
BR112016025866A2 (pt) 2014-05-07 2017-12-12 Applied Molecular Transp Llc composição farmacêutica, método para tratar uma doença anti-inflamatória em um indivíduo, método para tratar uma doença autoimune em um indivíduo, método para tratar um câncer em um indivíduo, uso de uma molécula de fusão que não ocorre naturalmente, método para tratar um distúrbio metabólico em um indivíduo, método para tratar uma doença hepática gordurosa em um indivíduo, método para tratar um distúrbio de deficiência de hormônio de crescimentoem um indivíduo, e, polinucleotídeo que codifica uma molécula de fusão
US10220076B2 (en) * 2014-05-15 2019-03-05 Incube Labs, Llc Pharmaceutical compositions and methods for fabrication of solid masses comprising glucose regulating proteins
US11548940B2 (en) 2014-05-15 2023-01-10 Rani Therapeutics, Llc Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
WO2016042301A1 (en) * 2014-09-17 2016-03-24 Mars, Incorporated Device
AU2015316581B2 (en) 2014-09-17 2020-06-11 Mars, Incorporated Device
CN113546036A (zh) * 2015-05-01 2021-10-26 拉尼医疗有限公司 药物组合物和用于制备包含多肽和/或蛋白质的固体块的方法
EP3294273A4 (en) * 2015-05-08 2018-12-05 Incube Labs, LLC Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
WO2017004623A1 (en) * 2015-07-02 2017-01-05 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
JP2018526403A (ja) * 2015-09-08 2018-09-13 インキューブ ラブズ， エルエルシー 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤
US10869840B2 (en) * 2016-03-09 2020-12-22 Incube Labs, Llc Methods and articles for delivering viable cells into solid tissue
AU2017322324B2 (en) 2016-09-09 2022-11-24 Biora Therapeutics, Inc. Electromechanical ingestible device for delivery of a dispensable substance
US20210138213A1 (en) * 2017-03-30 2021-05-13 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device
CN108095806B (zh) * 2017-12-16 2023-04-28 重庆金山科技（集团）有限公司 带自锁功能的吸附穿刺固定装置
CA3083068A1 (en) * 2017-12-18 2019-06-27 Biograil ApS Oral delivery of active drug substances
DK3762009T3 (da) 2018-03-08 2022-06-20 Applied Molecular Transport Inc Toxin-afledte indgivelseskonstrukter til oral indgivelse
CA3094925A1 (en) * 2018-03-30 2019-10-03 Vibrant Ltd. Gastrointestinal treatment system including a vibrating capsule, and method of use thereof
US20200093740A1 (en) * 2018-09-25 2020-03-26 Incube Labs, Llc Ingestible device with expandable enclosure
ES2911075T3 (es) 2018-11-07 2022-05-17 Applied Molecular Transport Inc Constructos de administración para transcitosis y métodos relacionados
WO2020096695A1 (en) 2018-11-07 2020-05-14 Applied Molecular Transport Inc. Cholix-derived carriers for oral delivery of heterologous payload
CN116726361A (zh) 2018-11-19 2023-09-12 比奥拉治疗股份有限公司 用生物治疗剂治疗疾病的方法和装置
KR20210124228A (ko) * 2018-12-31 2021-10-14 라니 테라퓨틱스, 엘엘씨 삼킬 수 있는 약물 전달 장치를 사용하여 장관의 내강으로 약물을 전달하기 위한 치료제 제제 및 방법
CN114599665A (zh) 2019-08-16 2022-06-07 应用分子转运公司 组合物、制剂及白细胞介素产生和纯化
WO2021119482A1 (en) 2019-12-13 2021-06-17 Progenity, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
US20230076683A1 (en) * 2021-09-03 2023-03-09 Alma Therapeutics Ltd Controlled Release Formulations and Methods of Targeted Drug Delivery within the Small Intestine Wall

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60129057A (ja) * 1983-12-14 1985-07-10 住友化学工業株式会社 針状固形製剤投与針
DK42093D0 (da) * 1993-04-07 1993-04-07 Bukh Meditec Administrationsmetode
GB2379390B (en) * 2001-09-11 2005-01-26 Caretek Medical Ltd A novel drug delivery technology
WO2004000389A2 (en) 2002-06-25 2003-12-31 Sung-Yun Kwon Rapidly dissolving micro-perforator for drug delivery and other applications
US8062573B2 (en) * 2002-09-16 2011-11-22 Theraject, Inc. Solid micro-perforators and methods of use
AU2003288516A1 (en) * 2002-12-26 2004-07-22 Given Imaging Ltd. Immobilizable in vivo sensing device
EP1594477A4 (en) * 2003-01-29 2009-07-15 Pill Pharma Ltd E ACTIVE MEDICATION CONTRIBUTION IN THE DIGESTIVE TUBE
FR2854072B1 (fr) * 2003-04-23 2006-08-04 Centre Nat Rech Scient Vecteur pour administration par voie orale
WO2006077528A2 (en) * 2005-01-18 2006-07-27 Koninklijke Philips Electronics, N.V. Electronically controlled capsule
JP4402648B2 (ja) * 2005-12-16 2010-01-20 オリンパス株式会社 被検体内導入装置
GB0603252D0 (en) * 2006-02-17 2006-03-29 Axcess Ltd Dissolution aids for oral peptide delivery
EP2300031B1 (en) * 2008-05-05 2017-09-20 Oramed Ltd. Methods and compositions for oral administration of exenatide
WO2010093834A2 (en) * 2009-02-12 2010-08-19 Incube Labs, Llc Skin penetrating device and method for subcutaneous solid drug delivery
HUP0900482A2 (en) * 2009-08-03 2011-03-28 Cera Med Kft Pharmaceutical formulation for oral administration
US8759284B2 (en) * 2009-12-24 2014-06-24 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
JP2013515576A (ja) * 2009-12-24 2013-05-09 インキューブ ラブズ， エルエルシー 嚥下可能薬物送達デバイスおよび薬物送達方法
CN109008910A (zh) * 2011-06-29 2018-12-18 拉尼医疗有限公司 用于使用可吞服药物递送装置递送到肠道内腔中的治疗药剂制剂

Also Published As

Publication number Publication date
EP2726091A1 (en) 2014-05-07
ES2773115T3 (es) 2020-07-09
JP6663326B2 (ja) 2020-03-11
JP6745866B2 (ja) 2020-08-26
CA2840617A1 (en) 2013-01-03
EP2726091A4 (en) 2015-04-15
AU2012275112B2 (en) 2017-07-06
CN104023740A (zh) 2014-09-03
JP2019043967A (ja) 2019-03-22
AU2012275112A1 (en) 2014-01-23
CA2840617C (en) 2020-03-24
PL2726091T3 (pl) 2020-08-10
PT2726091T (pt) 2020-04-22
EP3653224A1 (en) 2020-05-20
EP2726091B1 (en) 2020-01-22
JP7305008B2 (ja) 2023-07-07
CA3070695C (en) 2024-01-23
JP2016193946A (ja) 2016-11-17
JP2014520812A (ja) 2014-08-25
WO2013003824A1 (en) 2013-01-03
CN109008910A (zh) 2018-12-18
CN104023740B (zh) 2018-10-02
JP6029664B2 (ja) 2016-11-24
CA3070695A1 (en) 2013-01-03
JP2022126686A (ja) 2022-08-30
JP2020192342A (ja) 2020-12-03
JP7102470B2 (ja) 2022-07-19

Similar Documents

Publication Publication Date Title
DK2726091T3 (da) Præparater med terapeutisk middel til fremføring i et lumen i tarmkanalen ved hjælp af en synkbar anordning til lægemiddelfremføring
DK2890433T3 (da) Drivmekanisme med kontrolleret administation til lægemiddeladministrationspumper
DK2704776T3 (da) Enhed til en lægemiddelfremføringsanordning og lægemiddelfremføringsanordning
DK2736478T3 (da) Ventilarrangement til anvendelse med en væskebeholder og en medikamentampul
HK1198139A1 (en) Drug delivery medical device
DK2641614T3 (da) Farmaceutisk præparat integreret med mikronåle til hudbehandling
DK3603732T3 (da) Medikamentleveringssystem med en forsinkelsesmekanisme
EP2671603A4 (en) DEVICE FOR INJECTING MEDICINAL SOLUTIONS
DK3400981T3 (da) Fremgangsmåde og overvågningsanordning til overvågning af driften af en lægemiddelindgivelsesanordning
DK2768559T3 (da) Lægemiddelindgivelsesanordning
DK2849567T3 (da) Bærestoffer til forbedret lægemiddeladministration
IL232251B (en) Pharmaceutical combination for use in the treatment of type 2 diabetes patients
EP2676654A4 (en) DRUG DELIVERY DEVICE AND MEDICINE CALCULATION DEVICE USING THE SAME
DK2714135T3 (da) Medikamentadministrationsanordning og fremgangsmåde til styring af anordningen
EP2777731A4 (en) MEDICATION INJECTION DEVICE
DK2665503T3 (da) Medikamenttilførselsanordning
DK2686047T3 (da) Drivmekanisme til medicinafgivelsesanordning samt medicinafgivelsesanordning
DK2701773T3 (da) Dosisstyredele til injektionssprøjte
DK2452281T3 (da) Fremgangsmåde til at forudsige virkningen af lægemidler i en patient
HK1196267A1 (en) Pharmaceutical combination for use in glycemic control in diabetes type patients
EP2799101A4 (en) MEDICATION INJECTION DEVICE
PL2773648T3 (pl) Związki farmaceutyczne do zastosowania w terapii zakażenia clostridium difficile
DK2704778T3 (da) Drivindretning til en lægemiddeladministrationsanordning og tilsvarende lægemiddeladministrationsanordning
DK2740504T3 (da) Lægemiddelfremføringsanordning
DK2790758T3 (da) Kassette til en lægemiddeldosis og tilførselsindretning